Navigation Links
Potential Medtronic Infusion Pump Malfunction Claims: Resource4thePeople Attorneys Now Providing Consulations
Date:10/21/2013

s on its bone-growth product InFuse. The studies as published may have inaccurately represented InFuse’s risks and may have placed added weight on side effects of alternative treatments. Medtronic, which describes itself as 'the world's largest independent medical technology company,' also maintained significant, previously-undisclosed financial ties with physicians who authored studies about InFuse, making $210 million in payments to physicians over a 15-year period."

In a press release*** issued as part of the FDA Class 1 Recall Notice involving the SynchroMed Pumps, Medtronic officials provided additional details about the shorting problem:

"Medtronic has issued an Urgent Medical Device Correction notification to inform physicians about the potential for an electrical short within the SynchroMed pump. The FDA has classified this notification as a Class I recall.

"An electrical short could lead to pump motor stall and a subsequent loss of or reduction in therapy, which can result in the return of underlying symptoms and/or withdrawal symptoms. The SynchroMed II pump is equipped with alarms designed to alert the patient in the event of a motor stall.

"Medtronic encourages patients to contact their physicians immediately if they experience a return of symptoms or hear a device alarm. The cumulative failure rate due to this issue is less than one percent at seven years post implant. Because of the estimated low occurrence rate, the alarm safety feature and the risks associated with replacement surgery, Medtronic is not recommending removal of the devices unless a patient's pump shows signs of a malfunction. Medtronic is in the process of developing design updates to mitigate this issue."

Medtronic also provided the following details of how the devices are used:

"Physicians implant the devices in recipients’ lower abdomens underneath the skin, with one end of a catheter ins
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Potential new drug for some patients with treatment-resistant lung cancer
2. Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
3. Potential new drug effective in breast cancer and melanoma resistant to targeted therapies
4. New Research Shows Wild Blueberries Have Potential to Improve Heart Health
5. Macrophage-derived mediators may have potential as biomarkers for urinary stone risk
6. Repurposed antidepressants have potential to treat small-cell lung cancer
7. Quadruple Amputee and Champion Athlete Kyle Maynard to Inspire Special Needs Kids to Meet Greatest Potential
8. Warning of potential side effects of a product can increase its sales
9. McKenzie Management Develops New Tool To Measure Hidden Revenue Potential
10. Potential treatment for a specific kind of pancreatic cancer
11. Approved cancer drug potentially could help treat diabetes, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Diego, Calif. (PRWEB) October 30, 2014 ... longer mutually exclusive concepts in the medical-grade skin ... on the development of uniquely potent topical dermatological ... Health System ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 ... available glycolic acid concentrations (50% and 70%) and ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Radio listeners ... raising questions about the impact of traditional radio commercials ... method most likely to influence a purchasing decision. , ... of 525 consumers conducted by radio marketing company CRN ... categories, isolating the results of respondents who indicated they ...
(Date:10/30/2014)... Toronto, Canada (PRWEB) October 30, 2014 ... the area’s leading provider of non-medical, in-home senior care, ... activity to increased brain health. , The study, performed ... the ages of 60 and 78 over a week-long ... as opposed to daily physical activity. By examining the ...
(Date:10/30/2014)... 2014 USARAD Holdings Inc ... and specialty telemedicine solutions provider, including SecondOpinions.com ... existing teleradiology services at Mission Bend ER, it ... telemedicine services, to the state-of-the-art, 24/7, freestanding ER ... of this innovative partnership, there will be many ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
Breaking Medicine News(10 mins):Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3
... 25 OPKO Health, Inc. (Amex: OPK ),today ... C.,Pfenniger, Jr. to its Board of Directors. The company ... Mr. Pfenniger was,appointed to fill the vacancy created by ... created Board position., "The addition of Tom Beier ...
... $154 million, Announces Full Year 2008 Revenue Guidance of $204 ... and Reiterates ... Inc. (Nasdaq:,NUVA), a medical device company focused on developing products ... financial results for the full year ended December,31, 2007 and ...
... HOLLYWOOD, Calif., Jan. 25 IPC The,Hospitalist Company, Inc. ... announced yesterday the initial public offering of 5,200,000,shares of ... of $16.00 per share.,The Company has agreed to sell ... agreed to sell the remaining 1,900,000 shares of,common stock. ...
... Baxa Corporation announces,the launch of a targeted campaign ... delivery of quality therapy to patients, promoting,research and ... patients receiving IV therapy. The new campaign is ... Nurses Day. That day -- January 25, 2008 ...
... many as 30,000 deaths each year, study says , , ... contraceptives greatly reduce their risk of developing ovarian cancer, and ... new study confirms. , The use of oral contraceptives has ... cancer. The authors of the new study say their findings ...
... SAN DIEGO, Jan. 25 Plans put forward ... to healthcare will prove,impractical without more physicians and ... and Nurse Supply: The Missing Piece of the ... Healthcare, the largest,healthcare staffing company in the United ...
Cached Medicine News:Health News:OPKO Health Announces Changes to Board of Directors 2Health News:OPKO Health Announces Changes to Board of Directors 3Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 3Health News:IPC The Hospitalist Company, Inc. Prices Initial Public Offering 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 2Health News:Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver 3Health News:Oral Contraceptives Cut Ovarian Cancer Risk 2Health News:Oral Contraceptives Cut Ovarian Cancer Risk 3Health News:Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans 2Health News:Report: Too Few Physicians, Nurses to Implement Presidential Candidates' Health Reform Plans 3
(Date:10/30/2014)... , Oct. 30, 2014  Nektar Therapeutics (Nasdaq: ... the third quarter ended September 30, 2014 on Thursday, ... markets. Howard Robin , president and chief executive ... results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. ... and a live audio-only Webcast of the conference call ...
(Date:10/30/2014)... --  Auxilium Pharmaceuticals , Inc. (NASDAQ: ... today announced financial results for the third quarter ... corporate, commercial, regulatory and clinical development updates from ... pleased with the continued momentum and strong performance ... this quarter, especially the XIAFLEX franchise, which more ...
(Date:10/30/2014)...  TWi Pharmaceuticals, Inc. today announced that it has ... Drug Administration (FDA) on its Abbreviated New Drug Application ... generic equivalent to Eisai Inc.,s Aricept® 23mg.  Aricept® 23mg ... TWi Pharmaceuticals is preparing to launch the product in ... USA , at the earliest time ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22
... EntreMed, Inc. (Nasdaq: ENMD ) announced today that ... with YA Global Master SPV Ltd. ("YA Global"), a fund ... has the option, at its sole discretion, to sell, from ... to YA Global.  Concurrent with the signing of the SEDA, ...
... NEWPORT NEWS, Va., June 28, 2011  Burlington Medical ... new product into its inventory. The Single Swing-Arm Drape ... protects the worker from any scattered beams of radiation ... The black vinyl drape is 39-and-a-half inches wide ...
Cached Medicine Technology:EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 2EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 3EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown 4Burlington Medical Supplies Introduces Single Swing-Arm Drape 2
... Ankle Orthosis enables the clinician to ... ankle joint to control muscle imbalance ... a pair of bilateral turnbuckles, controlling ... Simply adjust the turnbuckle to gradually ...
... Protection,Protects the heel while maintaining the ankle ... contact with a soft, cushioning AliPlast™ foam ... and liner cradles the heel in a ... change position freely in bed from side-lying ...
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
SCD Sequential Compression System Intermittent Pneumatic Compression...
Medicine Products: